Publications: Dr Michael Austin
Othman J, Tiong IS, O'Nions J, Dennis M, Mokretar K, Ivey A, Austin M, Latif A-L et al.
(
2024
)
.
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy
.
Blood
vol.
143
,
(
4
)
336
-
341
.
Di Mambro A, Arroyo-Berdugo Y, Fioretti T, Randles M, Cozzuto L, Rajeeve V, Cevenini A, Austin MJ et al.
(
2023
)
.
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML
.
Oncogene
vol.
42
,
(
50
)
3670
-
3683
.
Austin MJ, Kalampalika F, Cawthorn WP, Patel B
(
2023
)
.
Turning the spotlight on bone marrow adipocytes in haematological malignancy and nonâmalignant conditions
.
British Journal of Haematology
vol.
201
,
(
4
)
605
-
619
.
Austin MJ, Halim L, Miraki-Moud F, Taussig D, Bomalaski J, Maher J, Gribben J, Szlosarek P et al.
(
2021
)
.
Priming Death Receptor Mediated Apoptosis with Arginine Starvation Sensitises Arginine Auxotrophic B-ALL to CAR-T
.
Blood
vol.
138
,
(
Supplement 1
)
Heydt Q, Xintaropoulou C, Clear A, Austin M, Pislariu I, Miraki-Moud F, Cutillas P, Korfi K et al.
(
2021
)
.
Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence
.
Nature Communications